About Us
COMPANY PROFILE
NINGBO SYNTAME BIOTECH CO.,LTD.
Ningbo SYNTAME Biotech Co., Ltd. (Brand: SYNTAME) is a National level Science and Technology Enterprise specializing in the R&D, production, and sales of pharmaceutical materials. It is committed to innovative drug process research, development, and optimization of drug replication processes to control costs, providing various drug-related products and technical solutions for the domestic and international pharmaceutical markets.
The company mainly focuses on the material of cardiovascular, diabetes and antipsychotic drugs, and its main products are Ezetimibe, Gliquidone, Pazopanib, SNAC, Sodium Caprate, Etc. The core R&D team has over 15 years of experience in drug development and production, with a fixed production base and a production capacity of over a thousand tons. They can produce special reactions such as Hydrogenation and Nitration, and undertake customized processing of high-end pharmaceutical intermediates and API. Our products are exported to international and domestic markets such as Europe, the United States, and Southeast Asia.
The company adheres to the management philosophy of "quality first, technological innovation", strengthens optimization management and technological innovation, and has passed EcoVadis certification, ISO9001: 2015 Quality Management System; ISO14001: 2015 Environmental Management System Certification; ISO45001: 2018 Occupational Health and Safety Management System Certification, strengthening management and skills training. The company has an independent research and development system, currently holds 3 invention patents, accepts 3 invention patents, and adheres to technological innovation.
Based on the market and closely following the development of the pharmaceutical industry, we sincerely invite domestic and foreign customers to develop together and achieve a win-win situation, and strive for the cause of human health.
COMPANY DEVELOPMENT HISTORY
2024
Patent approved: ZL2022 1 0679732.2 ECOVADIS certificated
2023
Ningbo Equity Exchange Center has innovatively listed with the code 783899. Certified by CQC for ISO9001, ISO14001, ISO45001, and CNAS. Outstanding incubated enterprises.
2022
Ningbo Syntame Technology R&D Center approved; Ningbo Excellent Incubated Enterprise; Rising Star Enterprise Patent approved:ZL2018 1 1302885.5
2021
Patent approved:ZL2019 1 1279292.3 Excellent Incubated Enterprise; Rising Star Enterprise
FACTORY FACILITIES
TESTING CENTER
HONOR
The company has passed the ISO9001:2015 quality management system; ISO14001: 2015 Environmental Management System Certification; ISO45001: 2018 Occupational Health and Safety Management System Certification, strengthening management and skills training. The company has an independent R&D system, currently holds 3 invention patents, accepts 3 invention patents, and adheres to technological innovation.
WHO CHOSE US?
